---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-014884"
form_type: "8-K"
ticker: "OMER"
cik: "0001285819"
company_name: "OMEROS CORP"
filed_at: "2022-10-06T23:59:59+00:00"
generated_at: "2026-06-23T04:56:18.595307+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Omeros sells portion of OMIDRIA royalties for $125M; total capped payments of $188.4M through 2030

## Summary
- Received $125M upfront from DRI Healthcare for partial sale of OMIDRIA royalties.
- DRI gets capped payments: $1.67M in 2022, $13M in 2023, $20M in 2024, $25M/yr 2025-28, $26.25M 2029, $27.5M 2030.
- Total payments to DRI capped at $188.4M; Omeros retains royalties above annual caps.
- No recourse to Omeros assets beyond purchased receivables; no financial covenants.
- Agreement terminates Dec 31, 2030 or when DRI receives all payments due.

## SEC filing metadata
- accession: 0001558370-22-014884
- form_type: 8-K
- ticker: OMER
- cik: 0001285819
- company_name: OMEROS CORP
- filed_at: 2022-10-06T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1285819/000155837022014884/0001558370-22-014884-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1285819/000155837022014884/omer-20220930x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-014884
- JSON: https://secwatch.observer/filing/0001558370-22-014884.json
- Plain text: https://secwatch.observer/filing/0001558370-22-014884.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.